• 1
    Ilgen MA, Trafton JA, Humphreys K. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend. 2006; 82:187193.
  • 2
    Barry DT, Beitel M, Garnet B, et al. Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry. 2009; 70:12131218.
  • 3
    Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000; 19:5362.
  • 4
    Larson M, Paasche-Orlow M, Cheng D, et al. Persistent pain is associated with substance use after detoxification: A prospective cohort analysis. Addiction. 2007; 102:752760.
  • 5
    Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006; 82:103110.
  • 6
    Potter J, Prather K, Weiss R. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008; 17:121125.
  • 7
    Potter J, Shiffman S, Weiss R. Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse. 2008; 34:101107.
  • 8
    Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003; 289:23702378.
  • 9
    Barry DT, Bernard MJ, Beitel M, et al. Counselors' experiences treating methadone-maintained patients with chronic pain: A needs assessment study. J Addict Med. 2008; 2:108111.
  • 10
    Barry DT, Irwin KS, Jones ES, et al. Opioids, chronic pain, and addiction in primary care. J Pain. 2010; 11:14421450.
  • 11
    Berg K, Arnsten J, Sacajiu G, et al. Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009; 24:482488.
  • 12
    Potter JS, Chakrabarti A, Domier CP, et al. Pain and continued opioid use in individuals receiving buprenorphine–naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010; 38(Suppl 1):S80S86.
  • 13
    Meade CS, Lukas SE, McDonald LJ, et al. A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. J Subst Abuse Treat. 2010; 38:1221.
  • 14
    Barry DT, Beitel M, Cutter CJ, et al. Conventional and non-conventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: A needs assessment study. J Addict Med. 2010; 4:8187.
  • 15
    Barry DT, Beitel M, Joshi D, et al. Pain and substance-related pain reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict. 2009; 18:117121.
  • 16
    Peles E, Schreiber S, Gordon J, et al. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005; 113:340346.
  • 17
    Sullivan L, Chawarski M, O'Connor P, et al. The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005; 79:113116.
  • 18
    Chakrabarti A, Woody GE, Griffin ML, et al. Predictors of buprenorphine–naloxone dosing in a 12-week treatment trial for opioid-dependent youth: Secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2010; 107:253256.
  • 19
    Garnet B, Beitel M, Cutter CJ, et al. Pain catastrophizing and pain coping among methadone-maintained patients. Pain Med. 2011; 12:7986.
  • 20
    Sheu R, Lussier D, Rosenblum A, et al. Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. Pain Med. 2008; 9:911917.
  • 21
    Stitzer ML, Chutuape MA. Other substance use disorders in methadone treatment: Prevalence, consequences, detection, and management. In: Strain EC, Stitzer ML, eds. Methadone Treatment for Opioid Dependence. Baltimore: Johns Hopkins University Press; 1999: 86117.
  • 22
    Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008; 92:267276.
  • 23
    Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004; 24:1041010415.